Showing 141 - 160 results of 19,255 for search 'THE*', query time: 0.09s Refine Results
  1. 141
  2. 142

    Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis by Manning Li, Ying Xie

    Published 2025-02-01
    “…In recent years, there has been controversy regarding whether adding Saccharomyces boulardii (S. boulardii) to traditional therapies is beneficial for eradicating H. pylori.AimTo evaluate the efficacy and safety of S. boulardii as an adjuvant therapy for the eradication of H. pylori.MethodsWe systematically searched the PubMed and Web of Science databases from January 2002 to January 2023. …”
    Get full text
    Article
  3. 143
  4. 144
  5. 145

    Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer by Franklin D. Gaylis, Bruno Emond, Ameur M. Manceur, Anabelle Tardif-Samson, Laura Morrison, Dominic Pilon, Patrick Lefebvre, Lorie A. Ellis, Hiremagalur Balaji, Andrea Ireland

    Published 2024-10-01
    “…Adequacy of BCG induction and maintenance was evaluated from the first BCG claim until the end of the patient’s observation, using a previously published claims-based algorithm (induction: ≥5 instillations within 70 days; induction and maintenance: ≥7 instillations within 274 days of first instillation) and a definition based on the landmark Southwest Oncology Group (SWOG) trial (induction: ≥5 instillations without gaps >7 days; followed by ≥2 instillations at month 3, 6, and every 6 months thereafter). Proportions of patients with adequate BCG induction and maintenance were reported overall and compared between those with and without CIS. …”
    Get full text
    Article
  6. 146
  7. 147

    A Brief Survey of Gender Parity in the Theatre Industry by Yeliz Biber Vangölü, Florentina Gümüş

    Published 2024-09-01
    Subjects: “…national theatre at home…”
    Get full text
    Article
  8. 148
  9. 149
  10. 150
  11. 151
  12. 152
  13. 153

    Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany by Jona T. Stahmeyer, Svenja Schauer, Siegbert Rossol, Hans Heinrich Wedemeyer, Daniel Wirth, Florence Bianic, Christian Krauth

    Published 2013-12-01
    “…The aim of the study was to assess the cost-effectiveness of triple therapy with telaprevir in Germany. **Methods:** We used a Markov model on disease progression and natural history to assess the cost-effectiveness of triple therapy with telaprevir compared to standard treatment with pegylated interferon and ribavirin. …”
    Get full text
    Article
  14. 154

    The role of Pharmaceutical Marketing in Prescribing Decisions in a Developing Country: A Comprehensive Study Exploiting Theory of Planned Behaviour by Mahmoud Al-Areefi, Mohamed Izham Mohamed Ibrahim, Abubakr Abdelraouf Alfadl

    Published 2024-11-01
    “…Conclusion: This research clarified the role played by pharmaceutical companies to influence prescribing decisions of physicians. Therefore, could provide theoretical framework for policymakers in Yemen, and other countries with similar conditions, to develop a suitable policy and strategy in terms of drug promotion.…”
    Get full text
    Article
  15. 155
  16. 156

    Incomplete Antenatal Steroid Therapy Can Enhance Outcomes in Preterm Infants with Emergency Conditions by Sebnem Calkavur, Senem Alkan Ozdemir, Ruya Colak, Ezgi Yangin Ergon, Ferit Kulali, Tulin Gokmen Yildirim

    Published 2020-03-01
    “… OBJECTIVE: We aimed to investigate the role of incomplete of antenatal steroid therapy by comparing with no and complete steroid exposure on mortality and morbidity in preterm infants. …”
    Get full text
    Article
  17. 157

    Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective by Ehab L. Atallah, Rodrigo Maegawa, Dominick Latremouille-Viau, Carmine Rossi, Annie Guérin

    Published 2022-08-01
    “…**Background:** Tyrosine kinase inhibitors (TKIs) are the standard-of-care treatment for chronic myeloid leukemia in chronic phase (CML-CP). Despite advances in therapy, there remains a proportion of patients with CML-CP that are refractory/intolerant to TKIs, and these patients cycle through multiple lines of therapy. …”
    Get full text
    Article
  18. 158

    Towards faster plan adaptation for proton arc therapy using initial treatment plan information by Benjamin Roberfroid, Margerie Huet-Dastarac, Elena Borderías-Villarroel, Rodin Koffeing, John A. Lee, Ana M. Barragán-Montero, Edmond Sterpin

    Published 2025-01-01
    “…Background and Purpose: Proton arc therapy (PAT) is an emerging modality delivering continuously rotating proton beams. …”
    Get full text
    Article
  19. 159

    Theoretical Foundations of Digital Content Integrity Expertise by Bobok I.I., Kobozieva A.A.

    Published 2025-02-01
    “…The ef-fectiveness of digital content integrity expertise methods is determined by their theoretical foun-dations. Existing theoretical approaches do not allow obtaining a final solution to this problem. …”
    Get full text
    Article
  20. 160